Xu Zhuo, Li Haotian, Qin Xuhua, Wang Tao, Hao Junjie, Zhao Jianwei, Wang Jiabo, Wang Ruilin, Wang Dan, Wei Shizhang, Cai Huadan, Zhao Yanling
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Department of Pharmacy, Fifth Medical Center, General Hospital of Chinese PLA, Beijing, 100039, China.
AMB Express. 2019 Jul 11;9(1):101. doi: 10.1186/s13568-019-0829-y.
Antibiotics abuse has caused increased bacterial resistance, which severely limits the application of antibiotics to the treatment of bacterial infections. Therefore, it is urgent to develop new antibacterial drugs through other sources. Dracontomelon dao (Blanco) Merr. & Rolfe (Ren Mianzi in Chinese) is a traditional medicinal material derived from Anacardiaceae with a long history of treating various infectious diseases, such as decubitus and skin ulcers. Recent research has indicated that different extracts from the leaves of D. dao, especially the ethyl acetate (EtOAc) fraction containing flavonoids and phenolic acids, exhibit potent antibacterial activities. In this research, the combined anti-drug-resistant bacterial activities of these active ingredients were investigated. Six samples (S1-S6) were obtained from the EtOAc fraction of D. dao leaves. Microcalorimetric measurements and principal component analysis were performed on the in vitro samples. The results showed that all six samples had notable antibacterial activities. Specifically, sample S6 exhibited a prominent antibacterial effect, with an IC value of 84.3 μg mL, which was significantly lower than that of other samples. The relative contents of main flavonoids and phenolic acids in S6 sample were confirmed by UPLC/Q-TOF-MS. In conclusion, sample S6 from the EtOAc fraction of D. dao leaves could be used as a potential antimicrobial resource in the treatment of infectious diseases. This work provides an insight into the effect of traditional Chinese medicine on drug-resistant bacteria. Moreover, the purification and characterization of the chemical compounds from the sample S6 deserve further analysis.
抗生素滥用导致细菌耐药性增加,这严重限制了抗生素在治疗细菌感染方面的应用。因此,迫切需要通过其他来源开发新的抗菌药物。人面子(Dracontomelon dao (Blanco) Merr. & Rolfe)是一种源自漆树科的传统药材,有着治疗各种传染病的悠久历史,如褥疮和皮肤溃疡。最近的研究表明,人面子叶的不同提取物,尤其是含有黄酮类化合物和酚酸的乙酸乙酯(EtOAc)馏分,具有强大的抗菌活性。在本研究中,对这些活性成分的联合抗耐药菌活性进行了研究。从人面子叶的乙酸乙酯馏分中获得了六个样品(S1 - S6)。对体外样品进行了微量量热法测量和主成分分析。结果表明,所有六个样品都具有显著的抗菌活性。具体而言,样品S6表现出突出的抗菌效果,IC值为84.3 μg/mL,明显低于其他样品。通过超高效液相色谱/四极杆飞行时间质谱(UPLC/Q - TOF - MS)确定了S6样品中主要黄酮类化合物和酚酸的相对含量。总之,人面子叶乙酸乙酯馏分中的样品S6可作为治疗传染病的潜在抗菌资源。这项工作为中药对耐药菌的作用提供了见解。此外,对样品S6中化合物的纯化和表征值得进一步分析。